Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
David J Browning, Chong Lee Department of Ophthalmology, Charlotte Eye, Ear, Nose and Throat Associates, PA, Charlotte, NC, USA Purpose: The aim of this study was to determine whether somatotype influences the risk of hydroxychloroquine (HC) retinopathy (HCR) and whether dosing by real body weight...
Main Authors: | Browning DJ, Lee C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-05-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/somatotype-the-risk-of-hydroxychloroquine-retinopathy-and-safe-daily-d-peer-reviewed-article-OPTH |
Similar Items
-
Selective Systematic Review of Ophthalmic Screening Methods for Hydroxychloroquine Associated Retinopathy
by: Begaye, Adrienne, et al.
Published: (2010) -
Update on hydroxychloroquine retinopathy
by: Remya Mareen Paulose, et al.
Published: (2017-01-01) -
Hydroxychloroquine retinopathy in a cohort of patients from upper Egypt
by: Mortada A Abozaid, et al.
Published: (2017-01-01) -
Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
by: Tangtavorn N, et al.
Published: (2016-11-01) -
Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline
by: Stephane Emonet, et al.
Published: (2015-01-01)